The benefits and drawbacks of home oxygen therapy for COPD: what’s next?

Yet H. Khor, Magnus Ekström

Forskningsoutput: TidskriftsbidragÖversiktsartikelPeer review

Sammanfattning

Introduction: Home oxygen therapy is one of the few interventions that can improve survival in patients with chronic obstructive pulmonary disease (COPD) when administered appropriately, although it may cause side effects and be an unnecessary burden for some patients. Areas covered: This narrative review summarizes the current literature on the assessment of hypoxemia, different types of home oxygen therapy, potential beneficial and adverse effects, and emerging research on home oxygen therapy in COPD. A literature search was performed using MEDLINE and EMBASE up to January 2024, with additional articles being identified through clinical guidelines. Expert Opinion: Hypoxemia is common in patients with more severe COPD. Long-term oxygen therapy is established to prolong survival in patients with chronic severe resting hypoxemia. Conversely, in the absence of chronic severe resting hypoxemia, home oxygen therapy has an unclear or conflicting evidence base, including for palliation of breathlessness, and is generally not recommended. However, beneficial effects in some patients cannot be precluded. Evidence is emerging on the optimal daily duration of oxygen use, the role of high-flow and auto-titrated oxygen therapy, improved informed decision-making, and telemonitoring. Further research is needed to validate novel oxygen delivery systems and monitoring tools and establish long-term effects of ambulatory oxygen therapy in COPD.

Originalspråkengelska
Sidor (från-till)469-483
Antal sidor15
TidskriftExpert Review of Respiratory Medicine
Volym18
Nummer7
DOI
StatusPublished - 2024

Bibliografisk information

Publisher Copyright:
© 2024 Informa UK Limited, trading as Taylor & Francis Group.

Ämnesklassifikation (UKÄ)

  • Lungmedicin och allergi

Fingeravtryck

Utforska forskningsämnen för ”The benefits and drawbacks of home oxygen therapy for COPD: what’s next?”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här